Differential in Vitro Effects of the Platelet Glycoprotein IIb/IIIa Inhibitors abixicimab or SR121566A on Platelet Aggregation, Fibrinogen Binding and Platelet Secretory Parameters - The first anti-integrin receptor therapeutics

Autor: Klinkhardt, U., Kirchmaier, C.M., Westrup, D., Breddin, H.K., Mahnel, R., Graff, J., Hild, M., Harder, S.
Zdroj: Thrombosis Research; 2000, Vol. 97 Issue: 4 p201-207, 7p
Databáze: Supplemental Index